Medium-dose intravenous immunoglobulin therapy for women with six or more recurrent miscarriages
Hideto Yamada(Hokkaido University), Yasuhiko Ebina(Kobe University), Yukari Nishino(Kobe University), Yuki Nakajima(Fujisawa City Hospital), Masashi Deguchi(Kobe University), Yoko Maesawa(Kobe University), Kenji Tanimura(Kobe University)
Cited by 13
Related Papers
Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester
|Reproductive Toxicology|2002|236
Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study
|BMJ Open|2011|129
Nucleosides and nucleotides. 100. 2'-C-Cyano-2'-deoxy-1-.beta.-D-arabinofuranosylcytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside
|Journal of Medicinal Chemistry|1991|85